MMedoramedoramd.ai

documentation

"18 Minutes to 4: 60 Days of Medora Inside a Real Allergy Clinic"

2026-09-24 · 2 min read

"18 Minutes to 4: 60 Days of Medora Inside a Real Allergy Clinic"

Most AI vendors show you a demo. This is a pilot — 60 days, a working

two-location allergy practice, and numbers that were measured, not modeled.

The practice is Allergy Affiliates, in Bradenton, Florida. Medora runs there

in production before it is offered to any other clinic, and the primary clinical

user driving the roadmap is Dr. Geetika Sabharwal, a board-certified

allergist. What follows is what actually happened.

The problem every allergist already knows

Skin-prick testing generates a lot of small, structured facts fast: dozens of

wheal and flare measurements, the panel used, the reaction pattern, the plan

that follows. Historically those facts get written on paper during the visit,

then transcribed into the chart afterward — usually after hours.

Before the pilot, provider sign-off on a skin-test visit note at Allergy

Affiliates took about 18 minutes. That is 18 minutes per visit spent

turning a completed encounter into a finished, signed note — time that comes

out of either the next patient or the evening.

What we measured over 60 days

  • 312 skin tests documented through Medora
  • Provider sign-off time: 18 minutes → 4 minutes per skin-test visit
  • Every single note reviewed and signed by a clinician — no exceptions

That last point is the one we care about most. Medora does not sign notes.

It drafts a complete, structured note from the visit and the measured results,

and a clinician reviews and signs it. The 4 minutes is review-and-sign time,

not blind acceptance.

Why the number moved

The reason sign-off dropped is not that the AI is clever. It is that the note

arrives already assembled from the same patient context the test came from —

the panel, the measurements, and the reaction pattern are already in the

structured note, traceable to where they came from. The clinician is checking

work, not re-entering it.

And because Medora's integration with IMS Meditab is live and native, the

reviewed note lands in the chart without a copy-paste step. For practices on

IMS, that removes the second half of the after-hours ritual entirely.

The honest caveats

  • This is one practice. 60 days, two locations, one specialty. It is a real

result, not a universal guarantee. Your panels, your EMR, and your workflow

will shift the numbers.

  • Skin-prick testing is where the gain is largest. The structured, repetitive

nature of SPT documentation is exactly what benefits most. A complex new-patient

history visit is a different shape of problem.

  • A clinician still reads every note. If your goal is documentation with no

human in the loop, Medora is the wrong tool. It is built for the opposite —

faster review, not absent review.

See it on your own visits

Medora's scribe is $99/month with a free trial — you can start on your own

and run it against your own visits, no procurement cycle required.

The 18-to-4 result came from a clinic doing the work every day, not from a

staged demo. The fastest way to know what it does for your practice is to

point it at one of your own skin-test visits.